Emicizumab Antibody
Emicizumab (ACE 910) is a bispecific antibody that substitutes for activated factor VIII by bridging factors IXa and Xa. It is applied in hemophilia A research, including in vitro coagulation studies and in vivo models for prophylactic and therapeutic effect evaluation.
Product Specifications
Product Name Alternative
RO 5534262, RO5534262, RO-5534262, Emicizumab, ACE 910, ACE910, ACE-910
Target
Factor VIII, Others
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Metabolism Research
Concentration
4.67 mg/mL
Purity
95.90% (May vary between batches)
Molecular Weight
145.14 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682313-500 1x 500 µL
Rb1 (Tumor Suppressor Protein) (RB1/2313R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
KN209258LP 1 Kit
Niemann Pick C1 (NPC1) Human Gene Knockout Kit (CRISPR)
Sign In for Pricing
View Details 
